-
EP1581214
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1581214
| EP1581214 - 4,5-DIARYLTHIAZOLE DERIVATIVES AS CB-1 LIGANDS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.11.2008 Database last updated on 02.11.2024 | Most recent event Tooltip | 28.11.2008 | Application deemed to be withdrawn | published on 31.12.2008 [2009/01] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [N/P] |
| Former [2005/40] | For all designated states AstraZeneca AB Sodertalje 151 85 / SE | Inventor(s) | 01 /
BERGGREN, Anna Ingrid K, AstraZeneca R & D Molndal Molndal 431 83 / SE | 02 /
BOSTROM, Stig Jonas, c/o AstraZeneca R & D Molndal Molndal 431 83 / SE | 03 /
ELEBRING, Stig Thomas, AstraZeneca R & D Molndal Molndal 431 83 / SE | 04 /
FALLEFORS, Linda, c/o AstraZeneca R & D Molndal Molndal 431 83 / SE | 05 /
WILSTERMANN, Johan M., AstraZeneca R & D Molndal Molndal 431 83 / SE | 06 /
GREASLEY, Peter, c/o AstraZeneca R & D Molndal 431 83 Molndal / SE | [2005/40] | Application number, filing date | 03782644.3 | 18.12.2003 | [2005/40] | WO2003GB05542 | Priority number, date | GB20020030087 | 24.12.2002 Original published format: GB 0230087 | [2005/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004058255 | Date: | 15.07.2004 | Language: | EN | [2004/29] | Type: | A1 Application with search report | No.: | EP1581214 | Date: | 05.10.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.07.2004 takes the place of the publication of the European patent application. | [2005/40] | Search report(s) | International search report - published on: | EP | 15.07.2004 | Classification | IPC: | A61K31/426, C07D277/56, C07D417/12, C07D417/04, A61K31/427, A61P25/28 | [2005/40] | CPC: |
C07D417/04 (EP,KR,US);
C07D277/56 (EP,KR,US);
A61K31/426 (KR);
A61P1/00 (EP);
A61P1/12 (EP);
A61P11/00 (EP);
A61P15/00 (EP);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P3/04 (EP);
A61P37/00 (EP);
A61P5/00 (EP);
A61P7/00 (EP);
A61P9/00 (EP);
C07D417/12 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/40] | Extension states | AL | 25.07.2005 | LT | 25.07.2005 | LV | 25.07.2005 | MK | 25.07.2005 | Title | German: | 4,5-DIARYLTHIAZOLE-DERIVATE ALS CB-1 LIGANDEN | [2005/40] | English: | 4,5-DIARYLTHIAZOLE DERIVATIVES AS CB-1 LIGANDS | [2005/40] | French: | DERIVÉS DE 4, 5-DIARYLTHIAZOLE UTILISÉS EN TANT QUE LIGANDS DU CB-1 | [2005/40] | Entry into regional phase | 25.07.2005 | National basic fee paid | 25.07.2005 | Designation fee(s) paid | 25.07.2005 | Examination fee paid | Examination procedure | 25.06.2004 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 23.06.2005 | Amendment by applicant (claims and/or description) | 25.07.2005 | Examination requested [2005/40] | 09.11.2006 | Despatch of a communication from the examining division (Time limit: M06) | 10.07.2007 | Reply to a communication from the examining division | 22.02.2008 | Communication of intention to grant the patent | 04.07.2008 | Application deemed to be withdrawn, date of legal effect [2009/01] | 11.08.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2009/01] | Request for further processing for: | 10.07.2007 | Request for further processing filed | 10.07.2007 | Full payment received (date of receipt of payment) Request granted | 23.07.2007 | Decision despatched | Fees paid | Renewal fee | 02.01.2006 | Renewal fee patent year 03 | 02.01.2007 | Renewal fee patent year 04 | 02.01.2008 | Renewal fee patent year 05 | 28.03.2008 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DXA]EP0377457 (FUJISAWA PHARMACEUTICAL CO [JP]) [DX] 1-5 * page 21, line 56 - page 25, line 55; claim - * [A] 6-10; | [A]WO0046209 (SANOFI SYNTHELABO [FR], et al) [A] 1-10 * page 8, line 24 - page 16, line 11; claim - *; | [A]EP1205478 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [A] 1-10 * page 95, line 40 - page 99, line 10; claim - *; | [PX]WO03078413 (SOLVAY PHARM BV [NL], et al) [PX] 1-3,8,9 * example - * | [A] - PERTWEE R G, "PHARMACOLOGY OF CANNABINOID RECEPTOR LIGANDS", CURRENT MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS BV, BE, (1999), vol. 6, no. 8, ISSN 0929-8673, pages 635 - 664, XP009024021 [A] 1-10 * the whole document * |